# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-24-066327
Filing Date
2024-08-08
Accepted
2024-08-08 07:06:48
Documents
24
Period of Report
2024-08-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea0210840-8k_aldeyra.htm iXBRL | 8-K | 26088
2 | ALDEYRA THERAPEUTICS, INC. PRESENTATION DATED AUGUST 8, 2024 | ea021084001ex99-1_aldeyra.htm | EX-99.1 | 17920
3 | ALDEYRA THERAPEUTICS, INC. PRESS RELEASE DATED AUGUST 8, 2024 | ea021084001ex99-2_aldeyra.htm | EX-99.2 | 18819
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 192015
5 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 639295
6 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 298558
7 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 241998
8 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 227833
9 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 340919
10 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 287156
11 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 264304
12 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 3720
| Complete submission text file | 0001213900-24-066327.txt |  | 3688347

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL SCHEMA FILE | aldx-20240808.xsd | EX-101.SCH | 3015
14 | XBRL LABEL FILE | aldx-20240808_lab.xml | EX-101.LAB | 34240
15 | XBRL PRESENTATION FILE | aldx-20240808_pre.xml | EX-101.PRE | 22359
26 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0210840-8k_aldeyra_htm.xml | XML | 3688

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 241185984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)